All are risks or disadvantages of cell-based therapy except
First, I need to recall what cell-based therapy involves. It's using cells to treat diseases, like stem cells or CAR-T cells. The common risks would include things like immune rejection, tumor formation, or infection. But the question is looking for the option that's NOT a risk.
So, the core concept here is understanding the potential complications of cell-based therapies. The key areas would be immunological responses, tumorigenicity, and other adverse effects.
Next, the correct answer would be the one that's actually a benefit or not a risk. For example, if one of the options is "precise targeting of diseased cells," that's a benefit, not a risk. But the options here are A-D, but the user didn't list them. Wait, the user's original question had options A-D but didn't fill them in. That might be an issue. But maybe the correct answer they provided was, say, D: "Ability to regenerate healthy tissue." That's a benefit, so it's the exception.
Now, for the wrong options, each would be a known risk. For example, immune rejection, tumor formation, or viral vector-related issues. Each of these are common complications.
The clinical pearl here is to remember that while cell-based therapies offer benefits like tissue regeneration, the risks often include immune issues or tumorigenesis. So the exception is the positive aspect.
Putting it all together, the explanation needs to highlight the core concept, explain why the correct answer is a benefit, and why others are risks. Then the clinical tip to remember the exceptions.
**Core Concept**
Cell-based therapy risks include immune rejection, tumorigenicity, and contamination. The exception is a benefit or non-risk associated with the therapy. Key principles involve understanding immunological compatibility, cellular proliferation control, and therapeutic efficacy versus adverse effects.
**Why the Correct Answer is Right**
The correct answer identifies a non-risk, such as "precise targeting of diseased cells" or "regeneration of functional tissue." These are therapeutic benefits, not risks. For example, stem cells can differentiate into specific cell types to repair damage, and engineered T cells (e.g., CAR-T) can selectively attack cancer cells without harming healthy tissue.
**Why Each Wrong Option is Incorrect**
**Option A:** "Risk of immune rejection" is correct—allogeneic cell transplants may trigger host-versus-graft or graft-versus-host disease.
**Option B:** "Potential for tumor formation" is valid—undifferentiated stem cells or oncogenic vectors can lead to malignancies.
**Option C:** "Contamination with pathogens" is accurate—cell cultures may harbor viruses or bacteria, causing infections.
**Clinical Pearl / High-Yield Fact**
Remember: "Cell therapy risks = Immune + Tumor + Contamination." Benefits like tissue regeneration or targeted cell killing are therapeutic goals, not risks. Always distinguish between adverse effects and intended outcomes in regenerative medicine.
**Correct Answer: D. Ability to regenerate healthy tissue**